Systemic Gene Delivery by Single-Dose Intracardiac Administration of scAAV2/9 and scAAV2/rh10 Variants in Newborn Rats - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles Human gene therapy methods Year : 2018

Systemic Gene Delivery by Single-Dose Intracardiac Administration of scAAV2/9 and scAAV2/rh10 Variants in Newborn Rats

Abstract

Abstract Recombinant adeno-associated virus serotype 9 (rAAV2/9) and pseudotype rhesus-10 (rAAV2/rh10) are used for gene delivery, especially into the central nervous system. Both serotypes cross the blood-brain barrier and mediate stable long-term transduction in dividing and nondividing cells. Among possible routes of administration, intracardiac injection holds the potential for widespread vector diffusion associated with a relatively simple approach. In this study adopting the intracardiac route, we compare the cell-specific tropism and transfection efficacy of a panel of engineered rAAV2/9 and rAAV2/rh10 vectors encoding the enhanced green fluorescent protein. We observed transduction in the brain and peripherally, with a predominant neuronal tropism while the various serotypes achieved different expression patterns.
Embargoed file
Embargoed file
Visibility date is undetermined

Dates and versions

inserm-02439491 , version 1 (28-03-2021)

Identifiers

Cite

Lucie Chansel-Debordeaux, Mathieu Bourdenx, Nathalie Dutheil, Sandra Dovero, Marie-Helene Canron, et al.. Systemic Gene Delivery by Single-Dose Intracardiac Administration of scAAV2/9 and scAAV2/rh10 Variants in Newborn Rats. Human gene therapy methods, 2018, 29 (4), pp.189-199. ⟨10.1089/hgtb.2017.192.r3⟩. ⟨inserm-02439491⟩

Collections

INSERM CNRS
36 View
1 Download

Altmetric

Share

Gmail Facebook X LinkedIn More